Combined Sleeve Gastrectomy and Omentoplasty Improves Inflammation and Insulin Resistance in Obese Rats with Type II Diabetes Mellitus: A Randomized Controlled Trials
Abstract
BACKGROUND: Diabetes mellitus (DM) is often associated with obesity, which can lead to chronic inflammation. Sleeve gastrectomy (SG) is a common treatment for obesity. Combining SG with omentoplasty, might help reducing inflammation in pancreatic beta cells. However, there is limited research regarding the combined effects of SG and omentoplasty in type 2 DM (T2DM). This study was conducted to fill this gap by evaluating the impact on body weight, insulin resistance, glucagon expression, and levels of interleukins (IL)-1, IL-6, and IL-10 in obese rats with type II DM.
METHODS: An experimental study was conducted on 18 obese Wistar rats with DM that were randomized into: control, T1 (SG), and T2 (SG + omentoplasty). SG involved the surgical removal of a portion of the stomach to reduce its size, while omentoplasty utilized the omentum to target inflammation in pancreatic beta cells. Venous blood samples were taken from subjects one day before and ten days after the intervention to measure the biomedical parameters with various methods. Data was statistically analyzed using paired t-tests for pre-test and post-test differences, and Post Hoc tests or Mann-Whitney tests for hypothesis testing.
RESULTS: All rats were confirmed to have obesity and DM according to the Lee index and blood glucose levels. T2 group exhibited a significant decrease in body weight, homeostatic model assessment of insulin resistance (HOMA-IR) values were lower, and glucagon expression, IL-1, IL-6, and IL-10 levels were significantly greater compared to both control and T1 groups.
CONCLUSION: The combination of SG and omentoplasty significantly improves inflammation and insulin resistance in obese rats with T2DM.
KEYWORDS: diabetes mellitus, sleeve gastrectomy, omentoplasty, inflammation, obesity
References
Tinajero MG, Malik VS. An update on the epidemiology of type 2 diabetes: A global perspective. Endocrinol Metab Clin North Am. 2021; 50(3): 337-55, CrossRef.
World Health Organization (WHO) [Internet]. Global Report on Diabetes [cited 2020 Jun 21]. Available from: https://www.who.int/.
Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et al. IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022; 183: 109119, CrossRef.
Khan MAB, Hashim MJ, King JK, Govender RD, Mustafa H, Al Kaabi J. Epidemiology of type 2 diabetes - Global burden of disease and forecasted trends. J Epidemiol Glob Health. 2020; 10(1): 107-11, CrossRef.
Ahmed B, Sultana R, Greene MW. Adipose tissue and insulin resistance in obese. Biomed Pharmacother. 2021; 137: 111315, CrossRef.
Lega IC, Lipscombe LL. Review: Diabetes, obesity, and cancer—Pathophysiology and clinical implications. Endocr Rev. 2020; 41(1): 33-52, CrossRef.
Garg SK, Maurer H, Reed K, Selagamsetty R. Diabetes and cancer: Two diseases with obesity as a common risk factor. Diabetes Obes Metab. 2014; 16(2): 97-110, CrossRef.
Meiliana A, Wijaya A. Metaflammation, NLRP3 inflammasome obesity and metabolic disease. Indones Biomed J. 2011; 3(3): 168-84, CrossRef.
Leitner DR, Frühbeck G, Yumuk V, Schindler K, Micic D, Woodward E, et al. Obesity and type 2 diabetes: Two diseases with a need for combined treatment strategies - EASO can lead the way. Obes Facts. 2017; 10(5): 483-92, CrossRef.
Sartika CR, Wijaya A, As’ad S. Pro-inflammatory profiles of Indonesian adult men with central obesity: A preliminary study on TNF-alpha, sTNFR-2 and IL-1beta. Indones Biomed J. 2010; 2(1): 66-72, CrossRef.
Tsilingiris D, Koliaki C, Kokkinos A. Remission of type 2 diabetes mellitus after bariatric surgery: Fact or fiction? Int J Environ Res Public Health. 2019; 16(17): 3171, CrossRef.
Koliaki C, Liatis S, le Roux CW, Kokkinos A. The role of bariatric surgery to treat diabetes: current challenges and perspectives. BMC Endocr Disord. 2017; 17(1): 50, CrossRef.
Akkary E, Duffy A, Bell R. Deciphering the sleeve: Technique, indications, efficacy, and safety of sleeve gastrectomy. Obes Surg. 2008; 18(10): 1323-9, CrossRef.
Juodeikis Ž, Brimas G. Long-term results after sleeve gastrectomy: A systematic review. Surg Obes Relat Dis. 2017; 13(4): 693-9, CrossRef.
Care D. Classification and diagnosis of diabetes: Standards of medical care in diabetes. Diabetes Care. 2019; 42(Suppl1): S13-S28, CrossRef.
Reed J, Bain S, Kanamarlapudi V. A review of current trends with type 2 diabetes epidemiology, aetiology, pathogenesis, treatments and future perspectives. Diabetes Metab Syndr Obes. 2021; 14: 3567-602, CrossRef.
Abdallah E, Fikry M, Rady O, Elfeki H. Plicated sleeve gastrectomy with combined mesocolon and greater omentum fixation after T-shaped omentoplasty: How to do it? Obes Surg. 2020; 30(3): 1173-4, CrossRef.
Di Nicola V. Omentum a powerful biological source in regenerative surgery. Regen Ther. 2019; 11: 182-91, CrossRef.
Malafaia AB, Nassif PAN, Ribas CAPM, Ariede BL, Sue KN, Cruz MA. Obesity induction with high fat sucrose in rats. Arq Bras Cir Dig. 2013: 26(Suppl 1): 17-21, CrossRef.
Skovsø S. Modeling type 2 diabetes in rats using high fat diet and streptozotocin. J Diabetes Investig. 2014; 5(4): 349-58, CrossRef.
Mueller A, Palilla S, Carter J. Optimal surgical treatment for type 2 diabetes: Sleeve gastrectomy or gastric bypass? Adv Surg. 2021; 55: 1-8, CrossRef.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7): 412-9, CrossRef.
Antunes LC, Elkfury JL, Jornada MN, Foletto KC, Bertoluci MC. Validation of HOMA-IR in a model of insulin-resistance induced by a high-fat diet in Wistar rats. Arch Endocrinol Metab. 2016; 60(2): 138-42, CrossRef.
Hady H, Dadan J, Gołaszewski P, Safiejko K. Impact of laparoscopic sleeve gastrectomy on body mass index, ghrelin, insulin and lipid levels in 100 obese patients. Wideochir Inne Tech Maloinwazyjne. 2012; 7(4): 251-9, CrossRef.
Hady HR, Dadan J, Luba M. The influence of laparoscopic sleeve gastrectomy on metabolic syndrome parameters in obese patients in own material. Obes Surg. 2012; 22(1): 13-22, CrossRef.
Collins D, Hogan AM, O’Shea D, Winter DC. The omentum: Anatomical, metabolic, and surgical aspects. J Gastrointest Surg. 2009; 13(6): 1138-46, CrossRef.
Pérez-Arana GM, Díaz-Gómez A, Bancalero-de los Reyes J, Gracia-Romero M, Ribelles-García A, Visiedo F, et al. The role of glucagon after bariatric/metabolic surgery: much more than an “anti-insulin” hormone. Front Endocrinol. 2023; 14: 1236103, CrossRef.
Capozzi ME, Wait JB, Koech J, Gordon AN, Coch RW, Svendsen B, et al. Glucagon lowers glycemia when β-cells are active. JCI Insight. 2019; 5(16): e129954, CrossRef.
Bancalero-delosReyes J, Camacho-Ramírez A, Fernández-Vivero J, Ribelles-García A, Macías-Rodríguez M, Almorza-Gomar D, et al. Glucagon-producing cell expansion in wistar rats: Changes to islet architecture after sleeve gastrectomy. Obes Surg. 2021; 31(5): 2241-9, CrossRef.
Akalu Y, Molla MD, Dessie G, Ayelign B. Physiological effect of ghrelin on body systems. Int J Endocrinol. 2020; 2020: 1385138. CrossRef.
Leon-Cabrera S, Arana-Lechuga Y, Esqueda-León E, Terán-Pérez G, Gonzalez-Chavez A, Escobedo G, et al. Reduced systemic levels of IL-10 are associated with the severity of obstructive sleep apnea and insulin resistance in morbidly obese humans. Mediators Inflamm. 2015; 2015: 493409. CrossRef.
Feijóo-Bandín S, Aragón-Herrera A, Moraña-Fernández S, Anido-Varela L, Tarazón E, Roselló-Lletí E, et al. Adipokines and inflammation: Focus on cardiovascular diseases. Int J Mol Sci. 2020; 21(20): 7711, CrossRef.
Gonzalez LL, Garrie K, Turner MD. Type 2 diabetes - An autoinflammatory disease driven by metabolic stress. Biochim Biophys Acta Mol Basis Dis. 2018; 1864(11): 3805-23, CrossRef.
DOI: https://doi.org/10.18585/inabj.v16i3.3047
Copyright (c) 2024 The Prodia Education and Research Institute
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Indexed by:
The Prodia Education and Research Institute
